AptarGroup : Aptar Reports 2019 Fourth Quarter and Annual Results
February 20, 2020 at 05:40 pm EST
Share
Aptar Reports Fourth Quarter and Annual Results; Recaps Year of Pharma Services Acquisitions and Multiple New Drug Delivery Launches; Highlights Strategic Steps to Strengthen Beauty Business
Crystal Lake, Illinois, February 20, 2020 - AptarGroup, Inc. (NYSE: ATR), a global leader in consumer dispensing, active packaging and drug delivery solutions and services, today reported its fourth quarter and full year 2019 financial results.
Fourth Quarter 2019 Summary
Reported sales decreased 2% and were negatively affected by changes in currency exchange rates
Core sales, excluding currency and acquisition effects, declined 1% including a negative impact from passing on lower resin costs
Core sales growth in our Pharma segment was offset by decreases in core sales in our other segments
Reported earnings per share of $0.73 (up 18% compared to the prior year)
Adjusted earnings per share of $0.80 (down 13% compared to the prior year)
Reported net income of $49 million (up 19% compared to the prior year)
Adjusted EBITDA of $131 million (down 7% compared to the prior year)
Subsequent to the end of the quarter:
Completed the previously announced equity investment in BTY, a leading Chinese provider of decorative and complete color cosmetics packaging solutions
As previously announced, entered into a binding agreement to acquire FusionPKG, a design and rapid go-to-market specialist for the North American beauty market
Announced plans to consolidate North American Beauty + Home footprint
Annual 2019 Summary
Reported sales increased 3%
Core sales, excluding currency and acquisition effects, grew 3%
Reported earnings per share of $3.66 (up 22% compared to the prior year)
Adjusted earnings per share of $3.95 (up 2% compared to the prior year)
Reported net income of $242 million (up 24% compared to the prior year)
Adjusted EBITDA of $592 million (up 8% compared to the prior year)
Net cash provided by operations of $514 million
Free cash flow of $272 million
Raised cash dividend 6% and achieved our 26th consecutive year of paying increased dividends
Returned $177 million to shareholders for the year in dividends and share repurchases
Made strategic investment in sustainable solutions partners PureCycle and Terracycle's Loop
Named one of America's Most Responsible Companies by Newsweek
Named one of America's Most Sustainable Companies by Barron's
Download the full press release
Attachments
Original document
Permalink
Disclaimer
AptarGroup Inc. published this content on 20 February 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 February 2020 22:39:17 UTC
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.
APTARGROUP, INC. 
